ArticleFrontiers in oncology2021

Lymphocyte-to-Monocyte Ratio Is the Independent Prognostic Marker of Progression in Patients Undergoing BCG-Immunotherapy for Bladder Cancer.

Mateusz Adamkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.